Publications
730
Citations
65,672
Est. group size
~1
Recurring co-author estimate
Active years
42
Publishing since 1985
Anne M. Fagan studies the biology of Alzheimer's disease and related dementias, focusing on biomarkers—measurable biological signals found in cerebrospinal fluid (the fluid around the brain and spinal cord), blood, and brain imaging—that can detect and track disease before and during symptom onset. Her work spans inherited (genetic) forms of Alzheimer's disease, frontotemporal dementia, and Down syndrome, often using long-term studies of the same individuals over many years. Recent projects also apply proteomics (large-scale protein measurement) and machine learning to understand how the disease develops and spreads in the brain.
Publication activity was consistently high (roughly 40–66 per year) through 2023, with substantially lower recorded counts in 2024–2026 that likely reflect incomplete indexing of very recent years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Continuous At-Home Monitoring of Nighttime Bed Behavior in Frontotemporal Dementia
Neurology Open Access · 2026
- 15 years of longitudinal genetic, clinical, cognitive, imaging, and biochemical measures in DIAN
npj Dementia · 2026
- Correlating hippocampal and amygdala volumes with neuropathological burden in Down syndrome and Alzheimer’s disease and related neurodegenerative pathologies using 7T postmortem MRI
Journal of Neuropathology & Experimental Neurology · 2025
- Distinct spatiotemporal atrophy patterns in corticobasal syndrome are associated with different underlying pathologies
Brain Communications · 2025
- Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia
Nature Medicine · 2025
- Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar Degeneration
JAMA Network Open · 2024
- Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging
EBioMedicine · 2024
- Higher amyloid is associated with greater loneliness among cognitively normal older adults during the COVID-19 pandemic
F1000Research · 2024
- Clinical performance of plasma P‐tau217 for the identification of primary Alzheimer’s disease pathology or co‐pathology in sporadic frontotemporal dementia
Alzheimer s & Dementia · 2024
- Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease
Nature Communications · 2024
- Axonal damage and inflammation response are biological correlates of decline in small-world values: a cohort study in autosomal dominant Alzheimer’s disease
Brain Communications · 2024
- Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer disease
medRxiv · 2023
- Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease
Science Translational Medicine · 2023
- CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
Nature Aging · 2023
- Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
Nature Medicine · 2023
- Alzheimer s & Dementia×204
- Neurology×18
- Journal of Alzheimer s Disease×15
- Brain×14
- Figshare×13
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile